Atlantic Health Strategies

The Behavioral Health Market Viability Test: A Go/No-Go Framework Before You Sign the Lease

Table of Contents

Ready to See Results?

From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.

The four-factor viability test operators should run before signing an LOI

A behavioral health market is viable when documented demand (SAMHSA prevalence and treatment-gap data plus local referral flow) exceeds licensed bed and slot capacity, the payer environment supports your intended level of care at sustainable rates, and regulatory conditions (Certificate of Need status, licensure moratoria, zoning) permit timely entry. Founders should validate all four factors, demand, supply, reimbursement, and regulatory access, before signing a lease or an LOI.

The reason most first-time operators skip this discipline is simple. They fall in love with a building. Then they back into the math. I have watched founders in Florida, Texas, and Georgia spend eighteen months and seven figures chasing a market that a two-week feasibility study would have killed on day three.

The four factors are not optional. They are the minimum an investment committee, a Huntington or Live Oak lender, or a serious PE sponsor will expect to see documented before they release capital. AHS treats them as a go/no-go gate, not a marketing exercise.

Factor one: demand you can actually document, not the demand you feel

The Behavioral Health Market Viability Test: A Go/No-Go Framework Before You Sign the Lease — Factor one: demand you can actually document, not the demand you feel

Prevalence alone is not demand. Treated demand is demand. Start with the SAMHSA National Survey on Drug Use and Health and pull county- and state-level SUD prevalence, then subtract what existing providers are already absorbing using FindTreatment.gov and BHSIS admission data.

The treatment gap is enormous and it is not closing. Past-year substance use disorder in 2024 held at roughly 16.8% of the population (48.4 million people), while only 3.5% (10.2 million) actually received substance use treatment in the past year, down from 4.6% (13.1 million) in 2023. On the mental health side, 48% of adults with any mental illness and 30% of adults with serious mental illness did not receive treatment in the past year. Those figures are your top-of-funnel. They are not your census projection.

Layer on HRSA Mental Health HPSA data to see where the professional supply gap is worst. As of December 31, 2025, HRSA counted 6,807 Mental Health HPSA designations covering roughly 137 million people, with only 27.29% of the need met and 6,800 additional practitioners required to remove the designations. A high-scoring HPSA overlay tells you something payers care about: network adequacy pressure. It also tells you where clinical recruitment will be hardest, which is the other side of the same coin.

Factor two: supply, licensure posture, and Certificate of Need before you tour a building

Every viable market has a real supply ceiling. Some of that ceiling is regulatory. Certificate of Need programs remain active in 35 states plus Washington, D.C., and behavioral health sits inside CON review in several of them for psychiatric beds, substance use residential, and sometimes even PHP and IOP depending on how the state defines a regulated service.

Recent legislative changes matter. In 2023, North Carolina passed HB 76, adjusting CON expense thresholds and exempting chemical dependency and psychiatric centers from the CON process. Georgia moved on birthing center CON in 2024, and Tennessee has been incrementally rolling back its list. Anyone quoting a 2019 CON summary to an investment committee is quoting a dead document.

Where CON does apply, understand the reality. Applying for a Certificate of Need can be a long and expensive process, often taking years and costing hundreds of thousands of dollars in legal and regulatory fees, and existing hospitals and healthcare providers can object to new applications, meaning established players can block new competitors by arguing there is no need for additional facilities or services. That is the timing and cost line item most first-time founders leave out of the pro forma entirely.

In non-CON states, the ceiling is still real. Florida AHCA moratoria on new SUD residential in certain counties, Texas HHSC licensure backlogs, and Georgia DBHDD provider-enrollment queues can all add six to twelve months to an opening date. Pull the actual pending-application list from the state before you sign anything.

Factor three and four: payer economics and the enforcement climate that will define your first three years

Demand and licensure are necessary. They are not sufficient. Reimbursement will decide whether the doors stay open.

Run a payer-mix stress test before you commit to a level of care. For residential and PHP (ASAM Criteria 4th Edition Level 2.5, which is outpatient), that means pulling the DOI network adequacy filings for the top commercial plans in the county, mapping the state Medicaid MCO fee schedules against your projected acuity mix, and testing whether an OTP or MAT service line requires DEA registration and state opioid treatment authority approval in the timeline your model assumes. As one CON policy critic often quoted by NCSL put it, letting incumbents object to new entrants is “like Burger King having the power to decide whether McDonald’s can open a new restaurant down the street.” The same dynamic shows up on the payer side, where dominant in-network providers slow-walk credentialing for new competitors.

Then overlay enforcement. HHS OIG work plans, state attorney general priorities, and CMS UPIC audits shape which levels of care are safe to build and which are radioactive in a given state. If a state AG has three active investigations of PHP billing patterns in your target MSA, your commercial book will be under SIU review inside twelve months of opening. That belongs in the pro forma as a reserve, not as a surprise.

Finally, count the fixed cost of market entry that founders routinely under-budget. On a typical 40-bed SUD residential build in Florida or Texas, AHS sees founders burn $1.2M to $2.5M in pre-revenue costs before the first admission: $75K to $150K for state licensure application work and consultants, $30K to $50K for The Joint Commission or CARF accreditation fees and survey window prep, $80K to $200K for EMR implementation and IT buildout, and six to nine months of clinical and admissions payroll (often $600K to $1.5M) while managed care contracting closes. If any of the four factors comes back weak, the answer is not to push harder. The answer is to pick a different market.

The Behavioral Health Market Viability Test: A Go/No-Go Framework Before You Sign the Lease — Factor three and four: payer economics and the enforcement climate that will define your first three years

Frequently asked questions

What data sources should I use to size a behavioral health market?
Start with SAMHSA NSDUH for prevalence, TEDS and BHSIS for admission volumes by level of care, FindTreatment.gov for licensed facility counts, HRSA HPSA data for provider supply, and KFF state Medicaid briefs and MACPAC for reimbursement context. Local referral flow (hospitals, drug courts, EAPs, unions) is the last mile and cannot be pulled from a federal dataset.

Does Certificate of Need apply to SUD or mental health treatment centers in my state?
It depends on the state and the level of care. CON programs are currently active in 35 states and Washington, D.C., but the list of regulated services varies widely, and states like North Carolina and Tennessee have recently narrowed what falls inside CON. Confirm the current statute and rules with the state health planning agency before you assume you are exempt.

How do I evaluate payer mix before opening a residential or PHP program?
Pull the state DOI network adequacy filings for the top three commercial payers, request current fee schedules for your ASAM Criteria 4th Edition levels of care through a broker or credentialing partner, and check Medicaid MCO per diems and utilization management rules. Model at least two scenarios: a slow-credentialing year one and a stable year two.

What is a healthy bed-to-population ratio for residential SUD treatment?
There is no single national benchmark, which is why operators must build a local ratio using BHSIS licensed capacity and NSDUH prevalence for the specific MSA. A market where treated demand already exceeds documented capacity by a wide margin and where HPSA scores are high is a stronger candidate than a market with an existing residential glut, regardless of population size.

How long does market feasibility due diligence typically take before signing a lease?
For a competent operator-grade feasibility study, plan on four to eight weeks. That covers demand modeling, supply and CON review, payer and reimbursement analysis, regulatory and enforcement scan, and a pro forma an investment committee will accept. Compressing it below four weeks is how founders end up with a signed lease in a market that will not support the model.

Request a Free Consultation

Scroll to Top